Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
Tuberculosis (TB) is the leading cause of death in the world from an infectious disease. Its etiologic agent, the Mycobacterium tuberculosis (Mtb), is a slow-growing bacterium that has coexisted in humans for thousands of years. According to the World Health Organization, 10.6 million new cases of T...
Saved in:
Main Authors: | Andrea Picchianti-Diamanti, Alessandra Aiello, Chiara De Lorenzo, Giovanni Battista Migliori, Delia Goletti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1494283/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
by: Alyssa Howren, et al.
Published: (2025-01-01) -
Genetic causality between insomnia and specific orthopedic conditions: Insights from a two-sample Mendelian randomization study
by: Mingyi Yang, et al.
Published: (2025-02-01) -
Pharmacological pain management in patients with rheumatoid arthritis: a narrative literature review
by: Natasha Cox, et al.
Published: (2025-01-01) -
Spectrum of spondyloarthritis
by: Himanshu Pathak, et al.
Published: (2020-01-01) -
Safety and efficacy of an Anti-CD20 Monoclonal antibody (RedituxTM) In Indian patients with seropositive rheumatoid arthritis
by: Arun Hegde, et al.
Published: (2018-01-01)